The Role of Buprenorphine in the Clinical Setting: MOUD and Chronic Pain – Part 1
Join Us Virtually
Event Details
Since the MATE-ACT took effect in June 2023, health care clinicians have been encouraged to incorporate Buprenorphine into clinical practice for persons with Opioid Use Disorders and/or Chronic Pain. In this session, we will explore the reasons why buprenorphine is used as a continuous medication and multiple ways buprenorphine is introduced and maintained in clinical settings.
Provide Activity Learning Objectives:
- Understand the role of buprenorphine and its risks and benefits in clinical settings of MOUD and chronic pain
- Review common processes and pathways used in inducing and maintaining buprenorphine safely in the clinical setting
- Discuss the need to establish a multidisciplinary health care team approach to patients on daily buprenorphine.
Session 2 is April 29
The Role of Buprenorphine in the Clinical Setting: MOUD and Chronic Pain - Part 2
Session 3 is May 27
The Role of Buprenorphine in the Clinical Setting: Latest research on buprenorphine use in other medical conditions
Craig Uthe, MD is a board-certified family physician with the American Board of Family Medicine and a member of the American Society of Addiction Medicine.He is the Medical Director of Professional Well-Being at Sanford Health and the Chief Well-Being Officer for the University of South Dakota Sanford School of Medicine.
For over twenty-five years, Dr. Uthe has been a medical advisor to the SD Health Professionals Assistance Program, an organization that provides management services to health care professionals with potentially impairing illnesses & addictions.
Dr. Uthe and his wife, Joyce, have three grown children and, more importantly, two grandsons, Luciano and Leonardo, who they enjoy spoiling upon every opportunity.